Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

More antiobesity proteins reported by Lilly

Nov. 25, 1996

Genentech advances NGF through the clinical development pipeline

Nov. 22, 1996

Cortecs plans oral insulin studies in diabetic patients

Nov. 22, 1996

Another French market introduction for Lescol

Nov. 22, 1996

Alkermes and Genentech expand collaboration for sustained-release human GH

Nov. 22, 1996

New impotence treatment deemed approvable by FDA

Nov. 22, 1996

Antidiabetic agents reported by Terumo

Nov. 22, 1996

First regulatory approval for impotence treatment

Nov. 21, 1996

Thrombopoietic activity of PEG-rHuMGDF established in cancer patients

Nov. 21, 1996

Solvay and TheraTech end HRT collaboration

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...